Palo Alto, United States
UpDoc, founded in 2023, is pioneering the transformative healthcare approach known as Remote Patient Intervention (RPI), leveraging the power of AI to enhance clinical care. Recognized for its innovative potential, this emerging technique gained credibility through a Stanford clinical trial published in JAMA Network Open, where RPI demonstrated significant advancements in healthcare quality and cost reduction.
Based in the United States and operating at the intersection of the AI and Health Care industries, UpDoc harnesses AI to perform physician-supervised “AI encounters.” These encounters aim to amplify healthcare delivery efficiency, evidenced by a 5X increase in clinical output and substantial improvements in medication adherence and chronic disease management.
In their latest Seed Round investment on January 5, 2024, UpDoc attracted backing from prestigious investors like Pear Ventures, Polaris Partners, Eli Lilly, Mayo Clinic, and Oxeon Partners, signaling strong confidence in their vision and disruptive potential within the healthcare sector.
